Medicare Enrolled
Dr. Nandkishore Ranadive, M.D.
Interventional Cardiology · Altamonte Springs, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ranadive from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ranadive? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ranadive
Dr. Nandkishore Ranadive is an interventional cardiology in Altamonte Springs, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ranadive performed 9,319 Medicare services across 5,099 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ranadive received a total of $44,208 from 52 pharmaceutical and/or device companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ranadive is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 8% volume in FL$ $44,208 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,319
Medicare services
Top 8% in FL for interventional cardiology
5,099
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~490 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,975 | $94 | $255 |
| Electrocardiogram (EKG), 12-lead | 847 | $11 | $29 |
| Remote patient monitoring device, 30 days | 610 | $38 | $105 |
| Echocardiogram, transthoracic | 472 | $145 | $394 |
| Hospital follow-up visit, high complexity | 330 | $96 | $206 |
| Remote pacemaker/defibrillator monitoring, 90 days | 259 | $16 | $46 |
| Remote patient monitoring management, 20 min/month | 227 | $38 | $99 |
| Remote pacemaker monitoring, 90 days | 214 | $22 | $62 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 214 | $19 | $55 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 213 | $26 | $69 |
| Injection, dipyridamole, per 10 mg | 210 | $3 | $13 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 186 | $15 | $37 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 183 | $137 | $470 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 176 | $89 | $188 |
| Regadenoson injection (Lexiscan) for heart stress test | 160 | $35 | $118 |
| New patient office visit (45-59 min) | 151 | $116 | $337 |
| Prothrombin time test (blood clotting) | 128 | $4 | $10 |
| Initial hospital admission, high complexity | 128 | $140 | $399 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 124 | $145 | $374 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 102 | $49 | $141 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 102 | $17 | $46 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 88 | $328 | $885 |
| Ultrasound of both sides of head and neck blood flow | 87 | $141 | $382 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 80 | $27 | $76 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 69 | $31 | $78 |
| Ultrasonic guidance for blood vessel access | 64 | $31 | $95 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 58 | $93 | $238 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 56 | $21 | $53 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 56 | $618 | $1,716 |
| Ultrasound of leg arteries or artery grafts | 52 | $170 | $481 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $39 | $100 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 48 | $854 | $2,230 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 44 | $146 | $330 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 43 | $742 | $2,728 |
| Heart muscle strain imaging | 39 | $29 | $76 |
| Insertion of stent in vein with review by radiologist, initial vein | 38 | $2,685 | $8,193 |
| Injection, aminophyllin, up to 250 mg | 37 | $9 | $14 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 36 | $19 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 35 | $40 | $116 |
| Review by radiologist of major lower body vein image | 34 | $91 | $335 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 33 | $9 | $22 |
| Insertion of stent in vein with review by radiologist, each additional vein | 30 | $1,333 | $4,850 |
| Insertion of tube into vein, second order branch | 29 | $339 | $2,296 |
| Hospital follow-up visit, moderate complexity | 28 | $64 | $144 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 28 | $320 | $798 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 26 | $106 | $317 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 26 | $32 | $87 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 24 | $41 | $83 |
| External shock to heart to regulate heart beat | 18 | $87 | $219 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 14 | $2,143 | $4,406 |
| Nuclear medicine study of heart muscle blood flow by pet | 14 | $142 | $354 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $44 | $148 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $982 | $2,512 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.1% high complexity
13.5% medium
74.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$44,208
Total received (2018-2024)
Avg $6,315/year across 7 years
Top 11% in FL for interventional cardiology
52
Companies
549
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29,712 (67.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,163 (29.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,333 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,613
2023$2,179
2022$5,621
2021$1,776
2020$1,567
2019$11,643
2018$19,809
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$16,174
Kowa Pharmaceuticals America, Inc.
$7,002
E.R. Squibb & Sons, L.L.C.
$5,649
AngioDynamics, Inc.
$3,089
BIOTRONIK INC.
$2,556
Abbott Laboratories
$1,846
Medtronic, Inc.
$825
Amgen Inc.
$717
Novartis Pharmaceuticals Corporation
$670
Medtronic Vascular, Inc.
$665
CVRx, Inc.
$664
Boston Scientific Corporation
$531
Boehringer Ingelheim Pharmaceuticals, Inc.
$484
Tactile Systems Technology Inc
$393
Merck Sharp & Dohme LLC
$361
Amarin Pharma Inc.
$356
Actelion Pharmaceuticals US, Inc.
$298
United Therapeutics Corporation
$200
Esperion Therapeutics, Inc.
$166
Philips Electronics North America Corporation
$164
SANOFI-AVENTIS U.S. LLC
$142
Intact Vascular, Inc.
$124
AstraZeneca Pharmaceuticals LP
$119
Janssen Pharmaceuticals, Inc
$95
Kiniksa Pharmaceuticals International, plc
$92
Gilead Sciences, Inc.
$77
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$71
Kiniksa Pharmaceuticals, Ltd.
$64
Bayer HealthCare Pharmaceuticals Inc.
$62
Alnylam Pharmaceuticals Inc.
$59
Novo Nordisk Inc
$54
Teleflex LLC
$47
SCPHARMACEUTICALS INC.
$39
Regeneron Healthcare Solutions, Inc.
$36
CashFlow Solutions, LLC
$25
Chiesi USA, Inc.
$25
Arrow International, Inc.
$24
Lexicon Pharmaceuticals, Inc.
$24
InfoBionic, Inc
$23
ATRICURE, INC.
$23
Baxter Healthcare
$20
Bard Peripheral Vascular, Inc.
$18
Impulse Dynamics (USA) Inc.
$17
Bardy Diagnostics, Inc.
$15
ORGANOGENESIS INC.
$14
Akcea Therapeutics, Inc.
$14
ZOLL Circulation Inc
$13
iRhythm Technologies, Inc.
$13
Coala Life Inc
$12
Reapplix Inc.
$12
Adhera Therapeutics, Inc.
$12
Kerecis Limited
$11
Top 3 companies account for 65.2% of total payments
Associated products mentioned in payments ›
(4067) Tack Endo Sys BTK · (4067) Tack Endovascular Systems BTK · 3C Patch Kit · ABRE · ALPHAVAC · Adempas · Allure Quadra RF CRT Pacemaker · Arcalyst · Assurity Pacemaker · Auryon · BELSOMRA · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CRT-Ds · Carnation Ambulatory Monitor · Coala Heart Monitor · Confirm Rx · Corlanor · ELIQUIS · EMPLICITI · ENTRESTO · EVKEEZA · Edora 8 DR-T · Ellipse ICD · EverFlex · FARXIGA · FLEXITOUCH · FUROSCIX · Flexitouch Plus · Fortify Assura · General - Therapies · HAWKONE · HawkOne · Hillrom - Carnation Ambulatory Monitor · IGT D Peripheral · IN.PACT ADMIRAL · IN.PACT Admiral · Interventional Products · JARDIANCE · KENGREAL · Kerecis Omega3 SurgiClose · LEQVIO · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · Livalo · MITRACLIP · MULTAQ · Manta · Mitra Clip system · MoMe Kardia · NEXLETOL · ONPATTRO · OPSUMIT · ORENITRAM · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRESTALIA · Puraply · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Repatha · Reveal LINQ · Rivacor · SILVERHAWK · SYMPLICITY G3 · SYNERGY ABLATION SYSTEM · SilverHawk · TEGSEDI · Tack Endovascular System · Temperature Management System · Trilogy 100 · UPTRAVI · VENACURE 1470 PRO · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Venclose Maven Catheter · Verquvo · WATCHMAN · XARELTO · Zero Gravity · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $474 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
28
Per 100K population
5.9
County median income
$83,030
Nearest hospital
ASPIRE HEALTH PARTNERS
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ranadive is a remote & electrophysiology specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (speaking/promotional, top 11%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ranadive experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ranadive performed 2,975 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ranadive receive payments from pharmaceutical companies?
Yes. Dr. Ranadive received a total of $44,208 from 52 companies across 549 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ranadive's costs compare to other interventional cardiologys in Altamonte Springs?
Dr. Ranadive's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ranadive) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Altamonte Springs
Browse interventional cardiologys in Altamonte Springs ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in FL
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in FL
Which FL interventional cardiologys receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Kowa Pharmaceuticals America, Inc. Payments to Doctors
See all physicians who received payments from Kowa Pharmaceuticals America, Inc..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology